Got, Jenisa M.

HRN: 06-88-56  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/25/2025
CEFUROXIME 1.5GM (VIAL)
09/25/2025
09/26/2025
IV
1.5gms
Q8hrs X 2 Doses
S/P Primary LSTCS With Intra-CS IUD
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines